Literature DB >> 26132966

Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review.

Padmaja Sudhakar1, David M Bachman, Alexander S Mark, Joseph R Berger, Sachin Kedar.   

Abstract

BACKGROUND: Progressive multifocal leukoencephalopathy (PML) is a severe often fatal opportunistic infection of the central nervous system caused by reactivation of a ubiquitous polyoma virus, JC virus. Although typically characterized by multifocal asymmetric subcortical white matter lesions, it may be monofocal and affect the cortical gray matter. Among the broad spectrum of clinical manifestations that occurs with PML, visual complaints are common. EVIDENCE ACQUISITION: Combination of representative personally observed cases of PML and comprehensive review of case series of PML from 1958 through 2014.
RESULTS: Neuro-ophthalmic signs and symptoms were reported in approximately 20%-50% of patients with PML and can be the presenting manifestation in half of these. A majority of these presentations occur from damage to cerebral visual pathways resulting in visual field defects, cortical blindness, and other disorders of visual association. Given the decreased frequency of infratentorial and cerebellar involvement, ocular motility disorders are less common.
CONCLUSIONS: Visual complaints occur in patients with PML and are often the presenting sign. Awareness of this condition is helpful in avoiding unnecessary delays in the diagnosis of PML and management of the underlying condition. Recent guidelines have established criteria for diagnosis of PML in the high-risk patient population and strategies to mitigate the risk in these populations.

Entities:  

Mesh:

Year:  2015        PMID: 26132966     DOI: 10.1097/WNO.0000000000000271

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  8 in total

Review 1.  Keeping it in check: chronic viral infection and antiviral immunity in the brain.

Authors:  Katelyn D Miller; Matthias J Schnell; Glenn F Rall
Journal:  Nat Rev Neurosci       Date:  2016-11-04       Impact factor: 34.870

2.  Progressive multifocal leukoencephalopathy during ixazomib-based chemotherapy.

Authors:  C P Sawicki; S A Climans; C C Hsia; J A Fraser
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

Review 3.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

Review 4.  Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.

Authors:  Deanna Saylor; Arun Venkatesan
Journal:  Curr Infect Dis Rep       Date:  2016-11       Impact factor: 3.725

5.  Progressive Multifocal Leukoencephalopathy with Negative JC Virus PCR following Treatment of Follicular Lymphoma: Implications for Biologics in the Era of Targeted Cancer Therapy.

Authors:  Kimberly A Silverio; Shyam A Patel
Journal:  Case Rep Oncol Med       Date:  2015-12-15

Review 6.  Progressive Multifocal Leukoencephalopathy.

Authors:  Laura Adang; Joseph Berger
Journal:  F1000Res       Date:  2015-12-10

7.  A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection.

Authors:  Jingjing Li; Ming Xue; Shuo Yan; Chunshuang Guan; Ruming Xie; Budong Chen
Journal:  BMC Infect Dis       Date:  2021-02-10       Impact factor: 3.090

Review 8.  Visual consequences of medications for multiple sclerosis: the good, the bad, the ugly, and the unknown.

Authors:  Heather E Moss
Journal:  Eye Brain       Date:  2017-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.